By NewsDesk @infectiousdiseasenews
People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City. For those few vaccinated people who do still get an infection, or “breakthrough” cases, the study suggests that vaccines reduce the severity of COVID-19 symptoms and shorten its duration.
Researchers say these results are among the first to show that mRNA vaccination benefits even those individuals who experience breakthrough infections.
“One of the unique things about this study is that it measured the secondary benefits of the vaccine,” says Sarang Yoon, D.O., a study co-author, assistant professor at the University of Utah Rocky Mountain Center for Occupational and Environmental Health (RMCOEH), and principal investigator of the RECOVER (Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel) study in Utah.
The study, published online in the New England Journal of Medicine, builds on preliminary data released by the Centers for Disease Control and Prevention (CDC) in March.
The study was designed to measure the risks and rates of infection among those on the front lines of the pandemic.
Read more at the University of Utah
- Brazil: Chikungunya cases up dramatically in São Paulo
- British Columbia: Rabies risk after contact with an injured bat at White Pine Beach, Belcarra
- Tyson Foods recall: Frozen, fully cooked chicken products due to possible Listeria
- Paraguay: Mass deworming for schoolchildren to restart this year
- Nicaragua leprosy: ‘We have managed to have a downward trend’
- Norway: Delta variant of the coronavirus has increased rapidly, not as quickly as Alpha variant